Stocks
GlaxoSmithKline (GSK) CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX, £ | ? | 2 258 000 000 | 2 258 000 000 | 2 258 000 000 | 2 344 000 000 | 2 344 000 000 | 2 689 000 000 | ||
| Changes by years, y/y, % | -23% | 0% | 0% | +4% | 0% | +5.5% | |||
GlaxoSmithKline. CAPEX, £
GlaxoSmithKline. CAPEX, changes, %
GlaxoSmithKline. CAPEX, sum by quarters, £
GlaxoSmithKline (GSK) CAPEX US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| CAPEX, £ | ? | 563 000 000 | 442 000 000 | 442 000 000 | 842 000 000 | 842 000 000 | 2 689 000 000 | |
| Changes by years, y/y, % | +6% | -17% | -17% | +69% | +69% | |||
| Changes by quarters, q/q, % | -28% | -21% | 0% | +90% | 0% | |||
